4/23
08:09 am
lxrx
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Medium
Report
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
4/18
08:04 am
lxrx
Lexicon Pharmaceuticals to Host 2024 Investor Day [Yahoo! Finance]
Low
Report
Lexicon Pharmaceuticals to Host 2024 Investor Day [Yahoo! Finance]
4/18
08:00 am
lxrx
Lexicon Pharmaceuticals to Host 2024 Investor Day
Low
Report
Lexicon Pharmaceuticals to Host 2024 Investor Day
4/16
01:19 pm
lxrx
All You Need to Know About Lexicon (LXRX) Rating Upgrade to Buy [Yahoo! Finance]
Medium
Report
All You Need to Know About Lexicon (LXRX) Rating Upgrade to Buy [Yahoo! Finance]
4/15
11:02 pm
lxrx
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) was upgraded by analysts at StockNews.com to a "sell" rating.
Medium
Report
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) was upgraded by analysts at StockNews.com to a "sell" rating.
4/11
08:06 am
lxrx
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
4/3
08:00 am
lxrx
Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Medium
Report
Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
3/25
09:38 am
lxrx
Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo [Yahoo! Finance]
Medium
Report
Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo [Yahoo! Finance]
3/25
09:20 am
lxrx
Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo
Medium
Report
Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo
3/13
02:28 pm
lxrx
Lexicon (LXRX) Dips on Post Hoc Analysis Data on Sotagliflozin [Yahoo! Finance]
Low
Report
Lexicon (LXRX) Dips on Post Hoc Analysis Data on Sotagliflozin [Yahoo! Finance]
3/12
08:17 am
lxrx
New Post Hoc Analysis of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment in Patients With Type 1 Diabetes and Chronic Kidney Disease [Yahoo! Finance]
Medium
Report
New Post Hoc Analysis of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment in Patients With Type 1 Diabetes and Chronic Kidney Disease [Yahoo! Finance]
3/12
08:00 am
lxrx
New Post Hoc Analysis of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment in Patients With Type 1 Diabetes and Chronic Kidney Disease
Medium
Report
New Post Hoc Analysis of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment in Patients With Type 1 Diabetes and Chronic Kidney Disease
3/11
07:35 am
lxrx
Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities [Yahoo! Finance]
High
Report
Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities [Yahoo! Finance]
3/11
07:35 am
lxrx
Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDA [Yahoo! Finance]
High
Report
Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDA [Yahoo! Finance]
3/11
07:17 am
lxrx
Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update [Yahoo! Finance]
3/11
07:15 am
lxrx
Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update
Medium
Report
Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update
3/11
07:05 am
lxrx
Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities
High
Report
Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities
3/11
07:00 am
lxrx
Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDA
High
Report
Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDA
2/2
07:33 am
lxrx
Postherpetic Neuralgia Market Insights: Anticipating Trends and Forecasted Growth Through 2032 [Yahoo! Finance]
Medium
Report
Postherpetic Neuralgia Market Insights: Anticipating Trends and Forecasted Growth Through 2032 [Yahoo! Finance]